AUSTIN, Texas, April 7, 2011 /PRNewswire/ — Luminex Corporation
(Nasdaq:
LMNX) has won a 2011 Medical Design Excellence Award in the
category of In Vitro Diagnostics for its innovative MAGPIX®
system. Introduced in 2010, MAGPIX is a compact, versatile
laboratory analysis platform designed to improve productivity by
delivering multiple highly accurate, reproducible results from a
single sample.
(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
MAGPIX can quickly detect and measure both proteins and nucleic
acids (DNA and RNA) in a variety of sample types. It simultaneously
performs up to 50 tests per sample, significantly reducing the
amount of sample, consumables and labor required over competing
systems. Capable of producing up to 4800 data points in
approximately one hour, it was designed for use by laboratory
scientists conducting disease-related research, pharmaceutical
R&D, and clinical laboratories.
“MAGPIX is an innovative and strategically important addition to
our portfolio that will make science and medicine faster and more
cost-effective for researchers and certain clinical labs,” said
Patrick J. Balthrop, president and CEO of Luminex Corporation. “It
is an honor to be recognized by MDEA for our efforts to bring
technology to market that is aimed at improving the health of
people around the world.”
Because of its compact and robust design, MAGPIX is being used
in a range of lab settings, including in emerging and developed
markets across the globe – from academic researchers in North
America and Europe as well as developing countries, to mobile
testing laboratories, to scientists with limited resources and
physical space.
MAGPIX was chosen for this prestigious award through a
comprehensive review by a multidisciplinary panel of third-p
‘/>”/>
SOURCE